Your browser doesn't support javascript.
loading
In Vitro and In Vivo Characterization of Tebipenem (TBP), an Orally Active Carbapenem, against Biothreat Pathogens.
Clayton, Nicholas P; Jain, Akash; Halasohoris, Stephanie A; Pysz, Lisa M; Lembirik, Sanae; Zumbrun, Steven D; Kane, Christopher D; Hackett, Michael J; Pfefferle, Denise; Smiley, M Autumn; Anderson, Michael S; Heine, Henry; Meister, Gabriel T; Pucci, Michael J.
Affiliation
  • Clayton NP; Spero Therapeutics Inc., Cambridge, MA nclayton@sperotherapeutics.com.
  • Jain A; Spero Therapeutics Inc., Cambridge, MA.
  • Halasohoris SA; US Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD.
  • Pysz LM; US Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD.
  • Lembirik S; US Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD.
  • Zumbrun SD; US Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD.
  • Kane CD; US Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD.
  • Hackett MJ; Battelle Memorial Institute, Columbus, OH.
  • Pfefferle D; Battelle Memorial Institute, Columbus, OH.
  • Smiley MA; Battelle Memorial Institute, Columbus, OH.
  • Anderson MS; Battelle Memorial Institute, Columbus, OH.
  • Heine H; Institute for Therapeutic Innovation, Department of Medicine, University of Florida, Orlando, FL.
  • Meister GT; Battelle Memorial Institute, Columbus, OH.
  • Pucci MJ; Spero Therapeutics Inc., Cambridge, MA.
Article in En | MEDLINE | ID: mdl-33593844

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Antimicrob Agents Chemother Year: 2021 Document type: Article Affiliation country: Morocco Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Antimicrob Agents Chemother Year: 2021 Document type: Article Affiliation country: Morocco Country of publication: United States